Enroll Online

Are HPCs from cord blood different from HPCs from other sources?

HPC antigens from cord blood are considered to be “immature” cells and are not required to be an exact match to be considered compatible, as opposed to HPCs from bone marrow or other blood. Because of this, researchers are confident that patients will experience fewer adverse reactions from HPCs from cord blood, as compared to other blood sources, because the body is less likely to view the cells as a threat and attack them.